Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGEN LTD.

(CGEN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about COMPUGEN LTD.
11/15Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating
MT
11/12COMPUGEN : Q3 Earnings Snapshot
AQ
11/12Compugen Narrows Net Loss in Q3, Revenue Gains on Milestone Payment
MT
11/12Press Release dated November 12, 2021 – “Compugen Presents Preliminary Resu..
PU
11/12Compugen Announces Collaboration Expansion with Bristol Myers Squibb alongside $20 Mill..
PU
11/12Compugen Presents Preliminary Results from Phase 1 Dose Escalation Monotherapy Study of..
PR
11/12Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Co..
PR
11/12Compugen Presents Preliminary Results from Phase 1/2 Dose Escalation Study of COM701 wi..
PR
11/12Compugen Reports Third Quarter 2021 Results
PR
11/12Compugen Presents Initial Translational Data Supporting the Differentiation of PVRIG Co..
CI
11/12Compugen Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended Sept..
CI
11/11Health Care Stocks Still Edging Lower Just Ahead of Thursday Close
MT
11/11Health Care Stocks Sinking Thursday
MT
11/11Compugen Receives $20 Million Investment From Bristol Myers; Shares Rise
MT
11/11Wall Street Set for Rebound After Sell-Off Fueled by Inflation Concerns
MT
11/11Compugen Shares Rise 18% Premarket After Bristol Myers Investment
DJ
11/11Compugen Announces Collaboration Expansion with Bristol Myers Squibb alongside $20 Mill..
PR
11/11Compugen Announces Collaboration Expansion with Bristol Myers Squibb Alongside $20 Mill..
CI
11/11Compugen Ltd. announced that it has received $19.999993 million in funding from Bristol..
CI
11/10Compugen Ltd. announced that it expects to receive $20 million in funding from Bristol-..
CI
11/08Compugen to Present at Upcoming Investor Conferences
PR
10/26Compugen to Release Third Quarter 2021 Results on Friday, November 12, 2021
PR
10/04COMPUGEN : Expects $6 Million Milestone Payment From AstraZeneca for First Patient Dosed i..
MT
10/04COMPUGEN : Announces Milestone Payment from AstraZeneca Triggered by First Patient Dosed w..
PR
10/04Compugen Ltd. Announces Milestone Payment from AstraZeneca Triggered by First Patient D..
CI
10/01COMPUGEN : To Present Clinical Data from anti-TIGIT COM902 Monotherapy and Triple Combinat..
PR
09/22COMPUGEN : Awarded Top 50 Most Promising Microsoft Solution Providers by CIOReview
AQ
09/14COMPUGEN : to Present at the Cantor Global Healthcare Conference
PU
08/26COMPUGEN : to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
PR
08/19COMPUGEN : Says AstraZeneca Will Launch Study on Lung Cancer Drug Candidate Based on Its C..
MT
08/19COMPUGEN : Announces Bispecific Antibody Derived from COM902 to Enter Clinical Development
PR
08/19Compugen Announces Bispecific Antibody Derived from COM902 to Enter Clinical Developmen..
CI
07/28COMPUGEN : Q2 Loss Widens as Expenses Climb
MT
07/28COMPUGEN : Q2 Earnings Snapshot
AQ
07/28COMPUGEN : Reports Second Quarter 2021 Results (Form 6-K)
PU
07/28COMPUGEN : Reports Second Quarter 2021 Results
PR
07/28Compugen Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
07/19COMPUGEN : Doses First Patient in Expansion Arm of Study Evaluating Triple Combination Ant..
MT
07/19COMPUGEN : Doses First Patient in Phase 1/2 Triple Combination Cohort Expansion of COM701 ..
PR
07/19Compugen Doses First Patient in Phase 1/2 Triple Combination Cohort Expansion of COM701..
CI
07/15COMPUGEN : Commences Dosing in Phase 1 Trial of Combo Therapy for Advanced Malignancies
MT
07/15COMPUGEN : Doses First Patient in Phase 1 Combination Study of COM902 and COM701 in Patien..
PR
07/15Compugen Doses First Patient in Phase 1 Combination Study of COM902 and COM701 in Patie..
CI
07/14COMPUGEN : to Release Second Quarter 2021 Results on Wednesday, July 28, 2021
PR
06/30COMPUGEN : Doses First Patient in Study of Combination Therapy to Treat Solid Tumors; Shar..
MT
06/30COMPUGEN : Doses First Patient in COM701/Opdivo« (nivolumab) Phase 1b Cohort Expansion Stu..
PR
06/30Compugen Doses First Patient in COM701/Opdivo« Phase 1b Cohort Expansion Study
CI
06/29COMPUGEN : Presents Research Supporting PVRIG as a Novel and Differentiated Checkpoint in ..
PR
06/29Compugen Ltd. Presents Research Supporting PVRIG as a Novel and Differentiated Checkpoi..
CI
06/08COMPUGEN : Preliminary biomarker data reveal immune activation evidenced by a trend of inc..
PU
06/08COMPUGEN : Announces Updated Data from Phase 1 Study of COM701, First- in-Class Anti-PVRIG..
PR
06/08Compugen Ltd. Updates Data from Phase 1 Study of COM701
CI
05/13COMPUGEN : Q1 Net Loss Widens; Shares Rise 5% Pre-Bell
MT
05/13COMPUGEN : Q1 Earnings Snapshot
AQ
05/13Compugen Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
05/11COMPUGEN TO PARTICIPATE AT SITC'S TA : A Deep Dive Seminar Series
PR
05/10COMPUGEN : Expands Research Collaboration with Johns Hopkins University for Novel Tumor Gr..
MT
05/10COMPUGEN : Announces Expansion of Research Collaboration with Johns Hopkins University for..
PR
05/10Compugen Ltd. Announces Expansion of Research Collaboration with Johns Hopkins Universi..
CI
05/03COMPUGEN : to Release First Quarter 2021 Results on Thursday, May 13, 2021
PR
04/27COMPUGEN : Publishes Preclinical Data Demonstrating Therapeutic Potential of COM902 in Can..
PR
04/27Compugen Publishes Preclinical Data Demonstrating Therapeutic Potential of COM902 in Ca..
CI
04/06COMPUGEN : SVB Leerink Adjusts Price Target on Compugen to $16 From $19, Maintains Outperf..
MT
03/08COMPUGEN : to Present at the Oppenheimer 31st Annual Healthcare Conference
PR
02/25COMPUGEN : Annual Report (SEC Filing - 20-F)
PU
02/25COMPUGEN : Q4 Loss Flat, Operating Expenses Rise
MT
02/25COMPUGEN : 4Q Earnings Snapshot
AQ
02/25Compugen Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020
CI
02/25COMPUGEN : Reports Fourth Quarter and Full Year 2020 Results
PR
02/25Compugen Ltd. Announces Data Update from Com701 Phase 1 Clinical Trial
CI
02/24Record redemption in Ark ETF sparks liquidity worries
RE
02/23BRISTOL MYERS SQUIBB : Compugen Expands Clinical Collaboration Agreement with Bristol Myer..
AQ
02/22COMPUGEN : Expands Clinical Collaboration With Bristol Myers to Support Its Expansion Stud..
MT
02/22Compugen Ltd. Enters into Amendment No. 2 to the Master Clinical Trial Collaboration Ag..
CI
02/22COMPUGEN : Expands Clinical Collaboration Agreement with Bristol Myers Squibb with Phase 1..
PR
1  2  3  4  5Next
Upcoming event on COMPUGEN LTD.